Former SUMMIT PHARMACEUTICALS
INTERNATIONAL CORP. |
Apr. 1985
Established as a SUMMIT PHARMACEUTICALS CORPORATION (100% capitalized by SUMITOMO CORPORATION). |
Sep. 1995
Inherited the trade rights and assets of Sumitomo Corporation's New Drug & Biotech Department. Changed the company name to SUMMIT PHARMACEUTICALS INTERNATIONAL CORPORATION. |
Oct. 2005
Transferred head office to Harumi Island Triton Square. |
Apr. 2006
Inherited the rights of marketing and developing scientific instruments from SC BIOSCIENCES CORPORATION. |
|
| Former SUMMIT MEDI-CHEM, LTD.
|
Nov.1949
Established as GOEI SHOJI KAISHA, LTD. |
Jun. 1993
Received investments from SUMITOMO CORPORATION. |
Apr. 2003
Transferred Tokyo office to Harumi Island Triton Square. Changed the company name to SUMMIT MEDI-CHEM, LTD.. |
Sep. 2003
Became a wholly owned subsidiary of SUMITOMO CORPORATION. |
|
